Artal Group S.A. Vigil Neuroscience, Inc. Transaction History
Artal Group S.A.
- $1.58 Billion
- Q2 2024
A detailed history of Artal Group S.A. transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Artal Group S.A. holds 1,828,691 shares of VIGL stock, worth $6.09 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
1,828,691
Previous 1,811,191
0.97%
Holding current value
$6.09 Million
Previous $6.18 Million
18.43%
% of portfolio
0.46%
Previous 0.33%
Shares
7 transactions
Others Institutions Holding VIGL
# of Institutions
58Shares Held
26.3MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$19.4 Million3.11% of portfolio
-
Northpond Ventures, LLC4.21MShares$14 Million58.42% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$6.04 Million0.22% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.69MShares$5.63 Million0.99% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.49MShares$4.95 Million0.02% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $94.1M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...